Measuring the impact of monoclonal antibody therapies (2023)
Attributed to:
Measuring the impact of monoclonal antibody drugs in cancer and rheumatoid arthritis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fmed.2023.1256712
PubMed Identifier: 38046416
Publication URI: http://europepmc.org/abstract/MED/38046416
Type: Journal Article/Review
Parent Publication: Frontiers in Medicine